首页 | 本学科首页   官方微博 | 高级检索  
文章检索
  按 检索   检索词:      
出版年份:   被引次数:   他引次数: 提示:输入*表示无穷大
  收费全文   1311篇
  免费   33篇
  国内免费   2篇
儿科学   10篇
妇产科学   147篇
基础医学   152篇
口腔科学   1篇
临床医学   50篇
内科学   30篇
皮肤病学   6篇
神经病学   344篇
特种医学   9篇
外科学   36篇
综合类   226篇
预防医学   68篇
药学   230篇
  1篇
中国医学   33篇
肿瘤学   3篇
  2023年   8篇
  2022年   15篇
  2021年   27篇
  2020年   21篇
  2019年   32篇
  2018年   27篇
  2017年   36篇
  2016年   36篇
  2015年   49篇
  2014年   99篇
  2013年   122篇
  2012年   79篇
  2011年   112篇
  2010年   81篇
  2009年   46篇
  2008年   48篇
  2007年   41篇
  2006年   40篇
  2005年   30篇
  2004年   31篇
  2003年   33篇
  2002年   28篇
  2001年   16篇
  2000年   18篇
  1999年   13篇
  1998年   18篇
  1997年   14篇
  1996年   13篇
  1995年   24篇
  1994年   17篇
  1993年   18篇
  1992年   14篇
  1991年   13篇
  1990年   14篇
  1989年   13篇
  1988年   24篇
  1987年   11篇
  1986年   9篇
  1985年   12篇
  1984年   9篇
  1983年   4篇
  1982年   7篇
  1981年   6篇
  1980年   2篇
  1978年   3篇
  1977年   5篇
  1975年   2篇
  1973年   2篇
  1972年   1篇
  1970年   1篇
排序方式: 共有1346条查询结果,搜索用时 0 毫秒
11.
Efficacy of misoprostol was studied for induction of labor at term. Seventy patients were randomized to Group A (n = 36, oral misoprostol 50 microg four hourly to maximum of 5 doses) and B (n = 34, continuous oxytocin infusion). Induction-delivery interval was shorter with misoprostol (7.7 +/- 2.8 h against 14.3 +/- 4.8 h with oxytocin) but the rates of vaginal delivery, cesarean, neonatal outcome variables were similar. Hence, misoprostol is an effective agent for induction of labor at term.  相似文献   
12.
OBJECTIVE: To investigate gene expressions for neurohypophyseal and ovarian hormones as well as their receptors in the endometrium of women with primary dysmenorrhoea and healthy subjects at ovulation. STUDY DESIGN: A group of eight women with moderate to severe dysmenorrhoea and eight healthy subjects were compared in parallel between 18 and 35 years of age, regularly menstruating, non-overweight and nulliparous. The study was performed at The Department of Obstetrics and Gynecology, University Hospital of Lund, Sweden. Endometrial biopsies were taken around the time of ovulation, which was determined by repeated ultrasound examinations. Receptor and gene expressions for oxytocin and vasopressin in the tissue were measured. RESULTS: The gene expression for oxytocin receptor was significantly lower in dysmenorrhoic than in healthy women, in median 1.21 and 3.44 oxytocin-receptor/actin, respectively (p=0.048). The expressions for oxytocin peptide, vasopressin V1a receptor, oestrogen receptor alpha, beta and progesterone receptor did not differ between the two groups. Expression of vasopressin peptide was not detectable. CONCLUSION: A lower oxytocin receptor gene expression at mid-cycle could be involved in the aetiology of primary dysmenorrhoea. However, the importance of a paracrine effect of oxytocin and its receptor at ovulation warrants further investigation.  相似文献   
13.
A review of the absorption, distribution, metabolism and excretion of ticrynafen (tienilic acid) in 8 animal species, including man, is presented. Although some species effects are apparent, ticrynafen absorption is essentially complete following oral administration. The compound is extensively bound to plasma proteins, primarily albumin. Consequently, tissue concentrations are generally lower than plasma concentrations. Plasma and whole body clearance of ticrynafen is rapid due both to metabolism and to extensive renal excretion of the compound and its metabolites. Male/female differences in renal excretion occur, with a subsequent effect on ticrynafen metabolism.

Ticrynafen is an inhibitor of reabsorption of sodium and uric acid by the kidney. This inhibitory effect, within the renal tubular lumen, accounts for its diuretic and uricosuric activity and could account for its antihypertensive activity, although a direct effect has also been claimed.

Ticrynafen is also a classical example of a competitive inhibitor of organic acid transport in the kidney and other organs. Much of the drug-drug interaction involving ticrynafen is understandable due to its effect on transport. However, potentiation of anticoagulant activity appears to involve some direct effects upon warfarin metabolism although ticrynafen, in general, is not an enzyme inducer or inhibitor.

Toxicity of ticrynafen is low in all animal species.  相似文献   
14.
The neuropeptides vasopressin (VP) and oxytocin (OT) and their receptors in the brain are involved in the regulation of various social behaviors and have emerged as drug targets for the treatment of social dysfunction in several sex-biased neuropsychiatric disorders. Sex differences in the VP and OT systems may therefore be implicated in sex-specific regulation of healthy as well as impaired social behaviors. We begin this review by highlighting the sex differences, or lack of sex differences, in VP and OT synthesis in the brain. We then discuss the evidence showing the presence or absence of sex differences in VP and OT receptors in rodents and humans, as well as showing new data of sexually dimorphic V1a receptor binding in the rat brain. Importantly, we find that there is lack of comprehensive analysis of sex differences in these systems in common laboratory species, and we find that, when sex differences are present, they are highly brain region- and species-specific. Interestingly, VP system parameters (VP and V1aR) are typically higher in males, while sex differences in the OT system are not always in the same direction, often showing higher OT expression in females, but higher OT receptor expression in males. Furthermore, VP and OT receptor systems show distinct and largely non-overlapping expression in the rodent brain, which may cause these receptors to have either complementary or opposing functional roles in the sex-specific regulation of social behavior. Though still in need of further research, we close by discussing how manipulations of the VP and OT systems have given important insights into the involvement of these neuropeptide systems in the sex-specific regulation of social behavior in rodents and humans.  相似文献   
15.
The aim of this study was to review different animal models of Central Diabetes Insipidus, a neurobiological syndrome characterized by the excretion of copious amounts of diluted urine (polyuria), a consequent water intake (polydipsia), and a rise in the serum sodium concentration (hypernatremia). In rodents, Central Diabetes Insipidus can be caused by genetic disorders (Brattleboro rats) but also by various traumatic/surgical interventions, including neurohypophysectomy, pituitary stalk compression, hypophysectomy, and median eminence lesions. Regardless of its etiology, Central Diabetes Insipidus affects the neuroendocrine system that secretes arginine vasopressin, a neurohormone responsible for antidiuretic functions that acts trough the renal system. However, most Central Diabetes Insipidus models also show disorders in other neurobiological systems, specifically in the secretion of oxytocin, a neurohormone involved in body sodium excretion.Although the hydromineral behaviors shown by the different Central Diabetes Insipidus models have usually been considered as very similar, the present review highlights relevant differences with respect to these behaviors as a function of the individual neurobiological systems affected. Increased understanding of the relationship between the neuroendocrine systems involved and the associated hydromineral behaviors may allow appropriate action to be taken to correct these behavioral neuroendocrine deficits.  相似文献   
16.
目的探讨缩宫素联合卡孕栓对剖宫产产后出血的疗效。方法将剖宫产的180例产妇随机分为两组。观察组104例在胎儿娩出后脐静脉给缩宫素20 U,同时产妇含舌下化卡孕栓1 mg;对照组76例在胎儿娩出后均子宫体注射缩宫素10 U,同时产妇舌下含化卡孕栓1 mg。比较不同时段剖宫产产后出血量,所获数据采用方差分析、t检验和X2检验。结果子宫收缩效果、止血效果、术中、术后及总出血量比较P均<0.005。结论剖宫产术中脐静脉推注缩宫素联合舌下含化卡孕栓,预防剖宫产术后出血效果显著。  相似文献   
17.
Objective: To compare the efficacy and safety of carbetocin and oxytocin in the prevention of postpartum hemorrhage after selective caesarean section. Methods: Two hundred and sixteen pregnant women who were going to deliver by caesarean section were randomly divided into two paralleled and controlled groups, of which the oxytocin group(group A) contained 105 women and the carbetocin group(group B) 111 women. 20 IU of oxytocin was administrated during operation for both groups, 10 IU directly into uterus and 10 IU intravenously. When the operation was over, 20 IU of oxytocin was dripped for group A lasting for 8 hours, while for group B 100μg of carbetocin was immediately injected intravenously for 1 minute. Blood loss as well as hemoglobin alteration was measured for the comparison of the effect of the two drugs. Blood biochemical indicators were introduced for the evaluation of the safety of carbetocin including the function of liver and kidney and the fasting glucose.Results: No significant difference was revealed between the two groups concerning the postpartum hemorrhage within 24 hours, the postpartum hemorrhage incidence and the changes of hemoglobin. There was no significant difference in the change of liver and kidney function, fasting glucose and electrolyte changes as well.Conclusions: Carbetocin has a similar effect and safety of oxytocin in controlling the blood loss of selective caesarean section.  相似文献   
18.
目的:研究卡前列素氨丁三醇注射液联合缩宫素预防产后出血的临床疗效。方法随机选取该院96例2015年1月一2016年2月收治的高危产妇,采用随机数字法分为对照组和观察组。观察组48例,娩出后给予卡前列素氨丁三醇注射液皮下注射联合缩宫素静脉滴注;对照组48例,仅注射缩宫素。观察两组患者产后出血量、出血率及不良反应。结果①观察组24 h内出血量明显低于对照组,出血例数少于对照组,出血率为2.1%,显著低于对照组16.7%,P<0.05;②对照组和观察组均有数例患者发生血压升高、恶心、呕吐、心悸等不良反应,不良反应发生率分别为16.7%、10.4%,对照组略高于观察组,但差异无统计学意义,P>0.05。结论卡前列素氨丁三醇注射液联合缩宫素预防产后出血效果较好,出血量、出血率均有显著改降低,不良反应未见增加,安全可靠。  相似文献   
19.
目的:探讨缩宫素结合米索前列醇治疗产后出血的临床价值。方法选择我中心2013年1月—2015年1月收治的100例产后出血患者为观察对象,随机将其分为对照组和试验组,对照组患者接受缩宫素治疗,试验组患者接受缩宫素结合米索前列醇治疗,比较分析2组患者的临床治疗效果。结果试验组产后24 h内平均出血量以及不良反应发生率均明显优于对照组(P<0.05)。结论产后出血患者接受缩宫素结合米索前列醇治疗,具有较高的有效性和安全性,因而临床应用价值较高。  相似文献   
20.
马平红 《当代医学》2016,(27):53-54
目的:探讨子宫肌瘤挖出术中应用垂体后叶素与催产素的效果。方法选取行子宫肌瘤挖出术患者68例,按照数字随机法分为2组:观察组34例于术中应用垂体后叶素,对照组34例于术中应用催产素,对比2组的临床预后。结果观察组的手术时间、手术出血、术后住院时间、手术前后Hb差值均显著低于对照组(P<0.05);观察组临床总有效率为94.12%,显著高于对照组的82.35%(P<0.05);2组不良反应率及术后复发率比较差异均无统计学意义。结论子宫肌瘤挖出术中应用垂体后叶素相比于催产素能够降低术中出血,提高手术安全性和有效性,改善临床预后,且不良反应较少,值得临床推广应用。  相似文献   
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号